A Study to Evaluate the Tolerability, Safety, and PK of AST-201 in Patients With GPC3-positive Advanced Solid Tumors

Clinical trial NCT06687941 · RECRUITING

Trial details

NCT number: NCT06687941
Sponsor: Aptamer Sciences, Inc.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Neoplasms Carcinoma, Hepatocellular Carcinoma, Non-Small-Cell Lung Liver Neoplasms

Start date: 2025-03-11
Primary completion: 2027-12-01
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.